Company: PHAT
Filing Date: 2025-04-01
Form Type: 8-K
Source: 0001193125-25-069748
Chunk: 4

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-01
Form: 8-K
Item: Item 5.02
Chunk 4
---
 or to comply with the Nasdaq acquisition and merger exception.

In accordance with the Nasdaq Listing Rules, awards under the Inducement Plan may only be made to individuals not previously employees or non-employeedirectors of the Company (or following such individuals’ bona fide period of non-employmentwith the Company), as an inducement material to the individuals’ entry into employment with the Company or being rehired following a bona fide period of interruption of employment by the Company, or, to the extent permitted by the Nasdaq Listing Rules, in connection with a merger or acquisition.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           PHATHOM PHARMACEUTICALS, INC.                                            
  Date: April 1, 2025      By:                                /s/ Molly Henderson                   
                                                              Molly Henderson                       
                                                              Chief Financial and Business Officer